Clinical Trial

Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

Study acronym: BLAAC PD
Recruiting
View on ClinicalTrials.gov →
Summary
BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-02.
Trial Details
NCT Number NCT06719583
Lead Sponsor Michael J. Fox Foundation for Parkinson's Research
Collaborators: University of Chicago, University of Alabama at Birmingham, Rush University, Washington University School of Medicine, Medical University of South Carolina, University Hospitals Cleveland Medical Center, Louisiana State University Health Sciences Center Shreveport, University of Florida, University of Maryland, The University of Texas Health Science Center, Houston, Ochsner Health System, Indiana University
Conditions Parkinson Disease
Enrollment 2,000 participants
Start Date 2020-11-16
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-27